Status:
RECRUITING
Duration of Doxycycline Treatment in MEM Patients
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Erythema Chronicum Migrans
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.
Eligibility Criteria
Inclusion
- • multiple erythema migrans
Exclusion
- pregnancy or lactation
- immunocompromised
- serious adverse event to doxycycline
- taking antibiotic with antiborrelial activity within 10 days
- extracutaneous manifestations of lyme borreliosis
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03337932
Start Date
May 1 2018
End Date
December 31 2027
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical center Ljubljana
Ljubljana, Slovenia